Internalization-dependent regulation of HT29 cell proliferation by neurotensin

Peptides

Volumn 27, Issue 10, 2006, Pages 2502-2507

  Navarro, Valérie ^a   Martin, Stéphane ^a   Mazella, Jean ^a  

^a CNRS   (France)

Author keywords

Cell growth; MAP kinases; Neurotensin; Neurotensin receptor 3

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROTENSIN; PHOSPHOLIPASE C; THYMIDINE;

ARTICLE; CANCER CELL CULTURE; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN HT29; COLON CANCER; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INTERNALIZATION; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION;

BIOLOGICAL TRANSPORT, ACTIVE; CELL PROLIFERATION; ENDOCYTOSIS; HT29 CELLS; HUMANS; INOSITOL PHOSPHATES; MAP KINASE SIGNALING SYSTEM; NEUROTENSIN; OSMOLAR CONCENTRATION; RECEPTORS, NEUROTENSIN; SUCROSE;

EID: 33748882839     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.04.028     Document Type: Article

References (30)

1. Amar S., Kitabgi P., and Vincent J.P. Activation of phosphatidylinositol turnover by neurotensin receptors in the human colonic adenocarcinoma cell line HT29. FEBS Lett 201 (1986) 31-36
2. Botto J.M., Chabry J., Sarret P., Vincent J.P., and Mazella J. Stable expression of the mouse levocabastine-sensitive neurotensin receptor in HEK 293 cell line: binding properties, photoaffinity labeling, and internalization mechanism. Biochem Biophys Res Commun 243 (1998) 585-590
3. Chen Z., Rola-Pleszczynski M., and Stankova J. Activation of ERK1/2 by platelet-activating factor receptor is independent of receptor internalisation and G-protein activation. Cell Signal 15 (2003) 843-850
4. Daaka Y., Luttrell L.M., Ahn S., Della Rocca G.J., Ferguson S.S., Caron M.G., et al. Essential role for G protein-coupled receptor endocytosis in the activation of mitogen-activated protein kinase. J Biol Chem 273 (1998) 685-688
5. Dal Farra C., Sarret P., Navarro V., Botto J.M., Mazella J., and Vincent J.P. Involvement of the neurotensin receptor subtype NTR3 in the growth effect of neurotensin on cancer cell lines. Int J Cancer 92 (2001) 503-509
6. Gendron L., Perron A., Payet M.D., Gallo-Payet N., Sarret P., and Beaudet A. Low-affinity neurotensin receptor (NTS2) signaling: internalization-dependent activation of extracellular signal-regulated kinases 1/2. Mol Pharmacol 66 (2004) 1421-1430
7. Iwase K., Evers B.M., Hellmich M.R., Kim H.J., Higashide S., Gully D., et al. Indirect inhibitory effect of a neurotensin receptor antagonist on human colon cancer (LoVo) growth. Surg Oncol 5 (1996) 245-251
8. Jans D.A. Nuclear signaling pathways for polypeptide ligands and their membrane receptors?. FASEB J 8 (1994) 841-847
9. Koch J., and Korbmacher C. Osmotic shrinkage activates nonselective cation (NSC) channels in various cell types. J Membr Biol 168 (1999) 131-139
10. Kramer H.K., and Simon E.J. mu and delta-opioid receptor agonists induce mitogen-activated protein kinase (MAPK) activation in the absence of receptor internalization. Neuropharmacology 39 (2000) 1707-1719
11. Maoret J.J., Anini Y., Rouyer-Fessard C., Gully D., and Laburthe M. Neurotensin and a non-peptide neurotensin receptor antagonist control human colon cancer cell growth in cell culture and in cells xenografted into nude mice. Int J Cancer 80 (1999) 448-454
12. Martin S., Navarro V., Vincent J.P., and Mazella J. Neurotensin receptor-1 and -3 complex modulates the cellular signaling of neurotensin in the HT29 cell line. Gastroenterology 123 (2002) 1135-1143
13. Mazella J., Zsurger N., Navarro V., Chabry J., Kaghad M., Caput D., et al. The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor. J Biol Chem 273 (1998) 26273-26276
14. Morinville A., Martin S., Lavallee M., Vincent J.P., Beaudet A., and Mazella J. Internalization and trafficking of neurotensin via NTS3 receptors in HT29 cells. Int J Biochem Cell Biol 36 (2004) 2153-2168
15. Petersen C.M., Nielsen M.S., Nykjaer A., Jacobsen L., Tommerup N., Rasmussen H.H., et al. Molecular identification of a novel candidate sorting receptor purified from human brain by receptor-associated protein affinity chromatography. J Biol Chem 272 (1997) 3599-3605
16. Pierce K.L., Maudsley S., Daaka Y., Luttrell L.M., and Lefkowitz R.J. Role of endocytosis in the activation of the extracellular signal-regulated kinase cascade by sequestering and nonsequestering G protein-coupled receptors. Proc Natl Acad Sci USA 97 (2000) 1489-1494
17. Pierce K.L., Tohgo A., Ahn S., Field M.E., Luttrell L.M., and Lefkowitz R.J. Epidermal growth factor (EGF) receptor-dependent ERK activation by G protein-coupled receptors: a co-culture system for identifying intermediates upstream and downstream of heparin-binding EGF shedding. J Biol Chem 276 (2001) 23155-23160
18. Poinot-Chazel C., Portier M., Bouaboula M., Vita N., Pecceu F., Gully D., et al. Activation of mitogen-activated protein kinase couples neurotensin receptor stimulation to induction of the primary response gene Krox-24. Biochem J 320 Pt 1 (1996) 145-151
19. Rostene W.H., and Alexander M.J. Neurotensin and neuroendocrine regulation. Front Neuroendocrinol 18 (1997) 115-173
20. Sadoul J.L., Mazella J., Amar S., Kitabgi P., and Vincent J.P. Preparation of neurotensin selectively iodinated on the tyrosine 3 residue. Biological activity and binding properties on mammalian neurotensin receptors. Biochem Biophys Res Commun 120 (1984) 812-819
21. Sarret P., Nouel D., Dal Farra C., Vincent J.P., Beaudet A., and Mazella J. Receptor-mediated internalization is critical for the inhibition of the expression of growth hormone by somatostatin in the pituitary cell line AtT-20. J Biol Chem 274 (1999) 19294-19300
22. Seethalakshmi L., Mitra S.P., Dobner P.R., Menon M., and Carraway R.E. Neurotensin receptor expression in prostate cancer cell line and growth effect of NT at physiological concentrations. Prostate 31 (1997) 183-192
23. Sehgal I., Powers S., Huntley B., Powis G., Pittelkow M., and Maihle N.J. Neurotensin is an autocrine trophic factor stimulated by androgen withdrawal in human prostate cancer. Proc Natl Acad Sci USA 91 (1994) 4673-4677
24. Shah B.H., Alberto Olivares-Reyes J., Yesilkaya A., and Catt K.J. Independence of angiotensin II-induced MAP kinase activation from angiotensin type 1 receptor internalization in clone 9 hepatocytes. Mol Endocrinol 16 (2002) 610-620
25. Trincavelli M.L., Tuscano D., Marroni M., Klotz K.N., Lucacchini A., and Martini C. Involvement of mitogen protein kinase cascade in agonist-mediated human A(3) adenosine receptor regulation. Biochim Biophys Acta 1591 (2002) 55-62
26. Turner J.T., James-Kracke M.R., and Camden J.M. Regulation of the neurotensin receptor and intracellular calcium mobilization in HT29 cells. J Pharmacol Exp Ther 253 (1990) 1049-1056
27. Vincent J.P., Mazella J., and Kitabgi P. Neurotensin and neurotensin receptors. Trends Pharmacol Sci 20 (1999) 302-309
28. Yamada M., Ohata H., Momose K., and Richelson E. Pharmacological characterization of SR 48692 sensitive neurotensin receptor in human pancreatic cancer cells, MIA PaCa-2. Res Commun Mol Pathol Pharmacol 90 (1995) 37-47
29. Zhao D., Zhan Y., Koon H.W., Zeng H., Keates S., Moyer M.P., et al. Metalloproteinase-dependent transforming growth factor-alpha release mediates neurotensin-stimulated MAP kinase activation in human colonic epithelial cells. J Biol Chem 279 (2004) 43547-43554
30. Zwaagstra J.C., El-Alfy M., and O'Connor-McCourt M.D. Transforming growth factor (TGF)-beta 1 internalization: modulation by ligand interaction with TGF-beta receptors types I and II and a mechanism that is distinct from clathrin-mediated endocytosis. J Biol Chem 276 (2001) 27237-27245